Perfusfind S.L.

Abstract Innovations in healthcare are growing exponentially, resulting in improved quality of and access to care, as well as rising societal costs of care and variable reimbursement. In recent years,..

Perfusfind S.L.

Abstract We report a series of four patients with CHD who tested positive for COVID-19, got treated, and underwent cardiac surgery in the same sitting. All had an uneventful perioperative..

Perfusfind S.L.

Abstract Background Extracorporeal cardiopulmonary resuscitation (eCPR) is a rapidly growing treatment strategy due to increasing survival rates in selected patients. Additional left ventricular mechanical unloading, using a transfemoral micro-axial blood..

Perfusfind S.L.

Abstract Introduction Weaning from cardiopulmonary bypass (CPB) is a critical step of any cardiac surgical procedure and often requires pharmacologic intervention. Calcium ions are pivotal elements for the excitation-contraction coupling..

Perfusfind S.L.

Abstract BACKGROUND:  Prospective, single-center trials have shown that the implementation of the Kidney Disease: Improving Global Outcomes (KDIGO) recommendations in high-risk patients significantly reduced the development of acute kidney injury..

Perfusfind S.L.

Abstract Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to..

Perfusfind S.L.

Abstract Objectives:  Soluble MER has emerged as a potential biomarker for delayed resolution of inflammation after myocardial injury and a therapeutic target to reduce cardiac-related morbidity and mortality in adults...

Perfusfind S.L.

Abstract Decision-making surrounding extracorporeal membrane oxygenation initiation and decannulation has become a key challenge in critical care. Nuanced communication skills and transparent discussions about prognosis are imperative during this lifesaving,..

Perfusfind S.L.

This case reports on a 83-year-old man, with a history of type 2 diabetes, hypertension, atrial fibrillation, and myocardial infarction, who was admitted to the intensive care unit (ICU) after..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a common treatment for cardiopulmonary failure. Although it can effectively reduce the mortality of patients with cardiopulmonary failure, it still has a high mortality..

Perfusfind S.L.

Abstract Objectives Patients after cardiac surgery with  (CPB) require a stay in the ICU postoperatively. This study aimed to investigate the incidence of prolonged length of stay (LOS) in the ICU..

Perfusfind S.L.

Abstract The coronavirus disease 2019 (COVID-19) pandemic began in the United States around March 2020. Because of limited access to extracorporeal membrane oxygenation (ECMO) in the authors’ region, a mobile..

Perfusfind S.L.

Abstract Foot drop in the absence of limb ischemia is a chronic complication in peripheral venoarterial extracorporeal membrane oxygenation (V-A ECMO) survivors; however, there is little published regarding the incidence and..

Perfusfind S.L.

Abstract Background: The hypothermic circulatory arrest (HCA) is an indispensable step in the surgical treatment of an acute type A aortic dissection (ATAAD), which could greatly affect the postoperative outcome. We..

Perfusfind S.L.

Abstract Background Miscommunication during clinical handover can lead to partial information transfer and healthcare provider dissatisfaction. We hypothesised that a quality improvement project to standardise the cardiovascular intensive care unit (CVICU)..

Perfusfind S.L.

Abstract Objectives The aim was to evaluate changes in the coagulation profile of cyanotic neonates, to analyze the effects of cardiopulmonary bypass (CPB) with crystalloid priming on their coagulation status,..

Perfusfind S.L.

Abstract Objective Biochemical and cytological pericardial fluid (PF) analysis is essentially based on the knowledge of pleural fluid composition. The aim of the present study is to identify reference intervals (RIs)..

Perfusfind S.L.

Abstract The use of extracorporeal life support (ECLS) is increasingly reported in adult liver transplantation (LT). However, neither the role of ECLS in the perioperative setting for LT nor its..

Perfusfind S.L.

Abstract Introduction: Modified ultrafiltration (MUF) is employed at the termination of cardiopulmonary bypass (CPB) in pediatric and neonatal patients undergoing congenital heart surgery to reduce the accumulation of total body..

Perfusfind S.L.

EOS ECMO is part of the LivaNova ECMO oxygenators family. Equipped with the well known Polymethylpentene Hollow Fiber, it guarantees optimal performance for Pediatric and Adult patients undergoing long duration..

Perfusfind S.L.

Goal-Directed Perfusion and the CONNECT GDPMonitor LivaNova, alongside leading clinicians who have studied the clinical benefits and improved patient outcomes associated with the application of Goal-Directed Perfusion (GDP), is at..

Perfusfind S.L.

The S5 Hybrid version is built on the S5 legacy and its proven reliability. This new addition to the LivaNova portfolio enables perfusionists to perform extracorporeal circulation with flexibility. With..

Perfusfind S.L.

Inspire is a complete family of adult oxygenators designed from years of research and laboratory experience, input from clinical experts from around the world and the application of advanced manufacturing..

Perfusfind S.L.

With more than 7,000 devices delivered and 5,5 million patients treated, perfusionists worldwide are benefiting from the reliability of the S5 heart-lung machine.• Proven safety and reliability • State of..

Perfusfind S.L.

MINIMALLY INVASIVE PERFUSIONINSPIRE® Min.I. is an innovative Minimally Invasive perfusion system bringing safety to the system level.INSPIRE® Min.I. allows a low hemodilution cardiopulmonary bypass (CPB).INSPIRE® Min.I. allows clinicians the choice..

Perfusfind S.L.

Small, sensitive neonatal and pediatric patients deserve dedicated perfusion systems.The Dideco KIDS line of pediatric oxygenators and arterial filters are the latest from a long history of pediatric perfusion advancements..

Perfusfind S.L.

Lilliput 2 ECMO is the new version completing the Lilliput oxygenators' family. Equipped with a long-term usage validated polymethylpentene membrane, it guarantees optimal performance for neonatal and infant patients undergoing..

Perfusfind S.L.

The Connect workflow system minimizes transcription errors, bias and all the drawbacks associated with manual operations.Connect allows trending and electronic transfer of data from LivaNova disposables. The perfusionist accesses all..

Perfusfind S.L.

TABLE OF CONTENTSArterial CannulaeVenous Return CannulaeCardioplegia ProductsVentsSuction ProductsThoracic CathetersBeating Heart ProductsAccessoriesMinimally Invasive Cardiac Surgery Cannulae[pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/09/LN_Adult-Cannulae-Catalogue_IM-02685_compressed.pdf" title="LN_Adult Cannulae Catalogue_IM-02685_compressed"]  

Perfusfind S.L.

LivaNova HEARTLINK is the first perfusion system automatically integrating perfusion data, critical patient parameters and product information to assist with implementation of Goal-Directed Perfusion, improved patient outcomes and increased clinical..